Synthesis of the data from previous studies reveals that, in cases of senile osteoporosis [25], diabetic osteoporosis [117], and chronic kidney disease—mineral and bone disorder [138], SGK1 demonstrates elevated expression levels and abnormal activation. Here, SGK1 is linked to osteoporosis.